A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Clinical trial NCT07024784 · RECRUITING

Trial details

NCT number: NCT07024784
Sponsor: AbbVie
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gynecologic Cancers Platinum-Sensitive Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer (PSOC)

Start date: 2025-07-30
Primary completion: 2028-01-01
Enrollment: 377

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.